Global Inhaled Nitric Oxide Delivery Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
Page: 109
Published Date: 02 Apr 2022
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Inhaled Nitric Oxide Delivery Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Inhaled Nitric Oxide Delivery Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hypoxic Respiratory Failure (HRF) accounting for % of the Inhaled Nitric Oxide Delivery Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inhaled Nitric Oxide Delivery Device for Children segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Inhaled Nitric Oxide Delivery Device include Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, and Beyond Air, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Inhaled Nitric Oxide Delivery Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inhaled Nitric Oxide Delivery Device for Children
Inhaled Nitric Oxide Delivery Device for Adults
Market segment by Application can be divided into
Hypoxic Respiratory Failure (HRF)
Acute Hypoxemic Respiratory Failure (AHRF)
Chronic Obstructive Pulmonary Disease (COPD)
Others
The key market players for global Inhaled Nitric Oxide Delivery Device market are listed below:
Mallinckrodt Pharmaceuticals
Getinge
Vero Biotech
LINDE
Beyond Air
Air Liquide Healthcare
Circassia Pharmaceuticals
NU MED
Bellerophon Therapeutics
Praxair Technology Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhaled Nitric Oxide Delivery Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inhaled Nitric Oxide Delivery Device, with price, sales, revenue and global market share of Inhaled Nitric Oxide Delivery Device from 2019 to 2022.
Chapter 3, the Inhaled Nitric Oxide Delivery Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhaled Nitric Oxide Delivery Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Inhaled Nitric Oxide Delivery Device market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Inhaled Nitric Oxide Delivery Device.
Chapter 13, 14, and 15, to describe Inhaled Nitric Oxide Delivery Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Inhaled Nitric Oxide Delivery Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inhaled Nitric Oxide Delivery Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Inhaled Nitric Oxide Delivery Device for Children
1.2.3 Inhaled Nitric Oxide Delivery Device for Adults
1.3 Market Analysis by Application
1.3.1 Overview: Global Inhaled Nitric Oxide Delivery Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hypoxic Respiratory Failure (HRF)
1.3.3 Acute Hypoxemic Respiratory Failure (AHRF)
1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
1.3.5 Others
1.4 Global Inhaled Nitric Oxide Delivery Device Market Size & Forecast
1.4.1 Global Inhaled Nitric Oxide Delivery Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Inhaled Nitric Oxide Delivery Device Sales in Volume (2017-2028)
1.4.3 Global Inhaled Nitric Oxide Delivery Device Price (2017-2028)
1.5 Global Inhaled Nitric Oxide Delivery Device Production Capacity Analysis
1.5.1 Global Inhaled Nitric Oxide Delivery Device Total Production Capacity (2017-2028)
1.5.2 Global Inhaled Nitric Oxide Delivery Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Inhaled Nitric Oxide Delivery Device Market Drivers
1.6.2 Inhaled Nitric Oxide Delivery Device Market Restraints
1.6.3 Inhaled Nitric Oxide Delivery Device Trends Analysis
2.1 Mallinckrodt Pharmaceuticals
2.1.1 Mallinckrodt Pharmaceuticals Details
2.1.2 Mallinckrodt Pharmaceuticals Major Business
2.1.3 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product and Services
2.1.4 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Getinge
2.2.1 Getinge Details
2.2.2 Getinge Major Business
2.2.3 Getinge Inhaled Nitric Oxide Delivery Device Product and Services
2.2.4 Getinge Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Vero Biotech
2.3.1 Vero Biotech Details
2.3.2 Vero Biotech Major Business
2.3.3 Vero Biotech Inhaled Nitric Oxide Delivery Device Product and Services
2.3.4 Vero Biotech Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 LINDE
2.4.1 LINDE Details
2.4.2 LINDE Major Business
2.4.3 LINDE Inhaled Nitric Oxide Delivery Device Product and Services
2.4.4 LINDE Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Beyond Air
2.5.1 Beyond Air Details
2.5.2 Beyond Air Major Business
2.5.3 Beyond Air Inhaled Nitric Oxide Delivery Device Product and Services
2.5.4 Beyond Air Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Air Liquide Healthcare
2.6.1 Air Liquide Healthcare Details
2.6.2 Air Liquide Healthcare Major Business
2.6.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product and Services
2.6.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Circassia Pharmaceuticals
2.7.1 Circassia Pharmaceuticals Details
2.7.2 Circassia Pharmaceuticals Major Business
2.7.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product and Services
2.7.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 NU MED
2.8.1 NU MED Details
2.8.2 NU MED Major Business
2.8.3 NU MED Inhaled Nitric Oxide Delivery Device Product and Services
2.8.4 NU MED Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bellerophon Therapeutics
2.9.1 Bellerophon Therapeutics Details
2.9.2 Bellerophon Therapeutics Major Business
2.9.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product and Services
2.9.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Praxair Technology Inc.
2.10.1 Praxair Technology Inc. Details
2.10.2 Praxair Technology Inc. Major Business
2.10.3 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product and Services
2.10.4 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3.1 Global Inhaled Nitric Oxide Delivery Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Inhaled Nitric Oxide Delivery Device
3.4 Market Concentration Rate
3.4.1 Top 3 Inhaled Nitric Oxide Delivery Device Manufacturer Market Share in 2021
3.4.2 Top 6 Inhaled Nitric Oxide Delivery Device Manufacturer Market Share in 2021
3.5 Global Inhaled Nitric Oxide Delivery Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Inhaled Nitric Oxide Delivery Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4.1 Global Inhaled Nitric Oxide Delivery Device Market Size by Region
4.1.1 Global Inhaled Nitric Oxide Delivery Device Sales in Volume by Region (2017-2028)
4.1.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2017-2028)
4.2 North America Inhaled Nitric Oxide Delivery Device Revenue (2017-2028)
4.3 Europe Inhaled Nitric Oxide Delivery Device Revenue (2017-2028)
4.4 Asia-Pacific Inhaled Nitric Oxide Delivery Device Revenue (2017-2028)
4.5 South America Inhaled Nitric Oxide Delivery Device Revenue (2017-2028)
4.6 Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue (2017-2028)
5.1 Global Inhaled Nitric Oxide Delivery Device Sales in Volume by Type (2017-2028)
5.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2028)
5.3 Global Inhaled Nitric Oxide Delivery Device Price by Type (2017-2028)
6.1 Global Inhaled Nitric Oxide Delivery Device Sales in Volume by Application (2017-2028)
6.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2028)
6.3 Global Inhaled Nitric Oxide Delivery Device Price by Application (2017-2028)
7.1 North America Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2028)
7.2 North America Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2028)
7.3 North America Inhaled Nitric Oxide Delivery Device Market Size by Country
7.3.1 North America Inhaled Nitric Oxide Delivery Device Sales in Volume by Country (2017-2028)
7.3.2 North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8.1 Europe Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2028)
8.2 Europe Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2028)
8.3 Europe Inhaled Nitric Oxide Delivery Device Market Size by Country
8.3.1 Europe Inhaled Nitric Oxide Delivery Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9.1 Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2028)
9.2 Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2028)
9.3 Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size by Region
9.3.1 Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10.1 South America Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2028)
10.2 South America Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2028)
10.3 South America Inhaled Nitric Oxide Delivery Device Market Size by Country
10.3.1 South America Inhaled Nitric Oxide Delivery Device Sales in Volume by Country (2017-2028)
10.3.2 South America Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11.1 Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2028)
11.2 Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2028)
11.3 Middle East & Africa Inhaled Nitric Oxide Delivery Device Market Size by Country
11.3.1 Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12.1 Raw Material of Inhaled Nitric Oxide Delivery Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Inhaled Nitric Oxide Delivery Device
12.3 Inhaled Nitric Oxide Delivery Device Production Process
12.4 Inhaled Nitric Oxide Delivery Device Industrial Chain
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Inhaled Nitric Oxide Delivery Device Typical Distributors
13.3 Inhaled Nitric Oxide Delivery Device Typical Customers
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Inhaled Nitric Oxide Delivery Device Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Inhaled Nitric Oxide Delivery Device Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Mallinckrodt Pharmaceuticals Major Business
Table 5. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product and Services
Table 6. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Getinge Basic Information, Manufacturing Base and Competitors
Table 8. Getinge Major Business
Table 9. Getinge Inhaled Nitric Oxide Delivery Device Product and Services
Table 10. Getinge Inhaled Nitric Oxide Delivery Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Vero Biotech Basic Information, Manufacturing Base and Competitors
Table 12. Vero Biotech Major Business
Table 13. Vero Biotech Inhaled Nitric Oxide Delivery Device Product and Services
Table 14. Vero Biotech Inhaled Nitric Oxide Delivery Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. LINDE Basic Information, Manufacturing Base and Competitors
Table 16. LINDE Major Business
Table 17. LINDE Inhaled Nitric Oxide Delivery Device Product and Services
Table 18. LINDE Inhaled Nitric Oxide Delivery Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Beyond Air Basic Information, Manufacturing Base and Competitors
Table 20. Beyond Air Major Business
Table 21. Beyond Air Inhaled Nitric Oxide Delivery Device Product and Services
Table 22. Beyond Air Inhaled Nitric Oxide Delivery Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Air Liquide Healthcare Basic Information, Manufacturing Base and Competitors
Table 24. Air Liquide Healthcare Major Business
Table 25. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product and Services
Table 26. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Circassia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Circassia Pharmaceuticals Major Business
Table 29. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product and Services
Table 30. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. NU MED Basic Information, Manufacturing Base and Competitors
Table 32. NU MED Major Business
Table 33. NU MED Inhaled Nitric Oxide Delivery Device Product and Services
Table 34. NU MED Inhaled Nitric Oxide Delivery Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bellerophon Therapeutics Basic Information, Manufacturing Base and Competitors
Table 36. Bellerophon Therapeutics Major Business
Table 37. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product and Services
Table 38. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Praxair Technology Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Praxair Technology Inc. Major Business
Table 41. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product and Services
Table 42. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Inhaled Nitric Oxide Delivery Device Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Inhaled Nitric Oxide Delivery Device Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Inhaled Nitric Oxide Delivery Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Inhaled Nitric Oxide Delivery Device Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Inhaled Nitric Oxide Delivery Device Production Site of Key Manufacturer
Table 48. Inhaled Nitric Oxide Delivery Device New Entrant and Capacity Expansion Plans
Table 49. Inhaled Nitric Oxide Delivery Device Mergers & Acquisitions in the Past Five Years
Table 50. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2017-2022) & (K Units)
Table 51. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2023-2028) & (K Units)
Table 52. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 55. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 56. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Inhaled Nitric Oxide Delivery Device Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Inhaled Nitric Oxide Delivery Device Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 61. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 62. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Inhaled Nitric Oxide Delivery Device Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Inhaled Nitric Oxide Delivery Device Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2022) & (K Units)
Table 67. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2023-2028) & (K Units)
Table 68. North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 71. North America Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 72. North America Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 73. North America Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 74. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2022) & (K Units)
Table 75. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2023-2028) & (K Units)
Table 76. Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 79. Europe Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 80. Europe Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 81. Europe Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 90. South America Inhaled Nitric Oxide Delivery Device Sales by Country (2017-2022) & (K Units)
Table 91. South America Inhaled Nitric Oxide Delivery Device Sales by Country (2023-2028) & (K Units)
Table 92. South America Inhaled Nitric Oxide Delivery Device Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Inhaled Nitric Oxide Delivery Device Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 95. South America Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 96. South America Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 97. South America Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Inhaled Nitric Oxide Delivery Device Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Inhaled Nitric Oxide Delivery Device Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales by Application (2023-2028) & (K Units)
Table 106. Inhaled Nitric Oxide Delivery Device Raw Material
Table 107. Key Manufacturers of Inhaled Nitric Oxide Delivery Device Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Inhaled Nitric Oxide Delivery Device Typical Distributors
Table 111. Inhaled Nitric Oxide Delivery Device Typical Customers
List of Figures
Figure 1. Inhaled Nitric Oxide Delivery Device Picture
Figure 2. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type in 2021
Figure 3. Inhaled Nitric Oxide Delivery Device for Children
Figure 4. Inhaled Nitric Oxide Delivery Device for Adults
Figure 5. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application in 2021
Figure 6. Hypoxic Respiratory Failure (HRF)
Figure 7. Acute Hypoxemic Respiratory Failure (AHRF)
Figure 8. Chronic Obstructive Pulmonary Disease (COPD)
Figure 9. Others
Figure 10. Global Inhaled Nitric Oxide Delivery Device Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Inhaled Nitric Oxide Delivery Device Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Inhaled Nitric Oxide Delivery Device Sales (2017-2028) & (K Units)
Figure 13. Global Inhaled Nitric Oxide Delivery Device Price (2017-2028) & (US$/Unit)
Figure 14. Global Inhaled Nitric Oxide Delivery Device Production Capacity (2017-2028) & (K Units)
Figure 15. Global Inhaled Nitric Oxide Delivery Device Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Inhaled Nitric Oxide Delivery Device Market Drivers
Figure 17. Inhaled Nitric Oxide Delivery Device Market Restraints
Figure 18. Inhaled Nitric Oxide Delivery Device Market Trends
Figure 19. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Manufacturer in 2021
Figure 20. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Manufacturer in 2021
Figure 21. Inhaled Nitric Oxide Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Inhaled Nitric Oxide Delivery Device Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Inhaled Nitric Oxide Delivery Device Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2017-2028)
Figure 25. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2017-2028)
Figure 26. North America Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (USD Million)
Figure 27. Europe Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (USD Million)
Figure 29. South America Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Inhaled Nitric Oxide Delivery Device Revenue (2017-2028) & (USD Million)
Figure 31. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
Figure 32. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2017-2028)
Figure 33. Global Inhaled Nitric Oxide Delivery Device Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 35. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2017-2028)
Figure 36. Global Inhaled Nitric Oxide Delivery Device Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
Figure 38. North America Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 39. North America Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2017-2028)
Figure 40. North America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2017-2028)
Figure 41. United States Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
Figure 45. Europe Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 46. Europe Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2017-2028)
Figure 47. Europe Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2017-2028)
Figure 48. Germany Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2017-2028)
Figure 57. China Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
Figure 64. South America Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 65. South America Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2017-2028)
Figure 66. South America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Inhaled Nitric Oxide Delivery Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Inhaled Nitric Oxide Delivery Device in 2021
Figure 78. Manufacturing Process Analysis of Inhaled Nitric Oxide Delivery Device
Figure 79. Inhaled Nitric Oxide Delivery Device Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Mallinckrodt Pharmaceuticals Getinge Vero Biotech LINDE Beyond Air Air Liquide Healthcare Circassia Pharmaceuticals NU MED Bellerophon Therapeutics Praxair Technology Inc.
Related Reports
05 Feb 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
